tetradecanoylphorbol acetate has been researched along with theanine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jeong, HJ; Kim, HM; Kim, NH | 1 |
Lai, XF; Lin, ZJ; Liu, XG; Mai, CL; Sun, SL; Tan, Z; Xu, YN; Zeng, WJ; Zhang, J; Zhou, LJ | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and theanine
Article | Year |
---|---|
Theanine is a candidate amino acid for pharmacological stabilization of mast cells.
Topics: Anaphylaxis; Animals; Anti-Allergic Agents; Cell Line; Gene Expression Regulation; Glutamates; Histamine; Humans; Hypersensitivity; Immunoglobulin E; Male; Mast Cells; Mice; NF-kappa B; p-Methoxy-N-methylphenethylamine; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2012 |
Topical delivery of l-theanine ameliorates TPA-induced acute skin inflammation via downregulating endothelial PECAM-1 and neutrophil infiltration and activation.
Topics: Administration, Topical; Animals; Cell Proliferation; Cyclooxygenase 2; Down-Regulation; Ear; Edema; Female; Glutamates; Inflammation; Interleukin-1beta; Mice; Neutrophil Infiltration; Neutrophils; Permeability; Platelet Endothelial Cell Adhesion Molecule-1; Skin; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2018 |